The global peptide and anticoagulant drugs market is projected to register a CAGR of 3.3% during the forecast period (2024-2031). Key companies operating in the industry are highly inclined toward the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in September 2021, Nimble Therapeutics entered into a strategic research collaboration with Incyte to include the discovery of additional novel peptide therapies. The collaboration leveraged Nimble’s proprietary peptide synthesis, screening, and optimization platform coupled with its high chemical diversity and integrated suites of assays to enable faster discovery of compounds for intercellular and extracellular targets ensuring maximal patient impact across multiple disease indications.
Get Free Sample link @ https://www.omrglobal.com/request-sample/peptide-and-anticoagulant-market
Furthermore, in May 2021, ISSAR Pharmaceuticals has decided to license out their peptide-based new chemical entities (NCEs) with pre-IND filing and US patent for various unmet healthcare needs of the population and making it affordable and accessible for better health outcomes. in February 2021, The Stony Brook Study discovered that using an anticoagulation therapy based on blood serum D-dimer levels reduced mortality in critically ill Covid-19 Patients. In September 2020, Mylan N.V has acquired Aspen Pharmacare Holdings Ltd thrombosis business in Europe. The main aim of the acquisition is to expand access to complex injectables by adding sales and marketing to strengthen the company’s reach in hospitals. Moreover, in February 2019, Blackstone Lifesciences launched Anthos Therapeutics, a biopharmaceutical company. This launch aimed to enable next-generation therapies for high-risk cardiovascular patients. Thus, key acquisitions, developments, collaborations, launches, and growth strategies are boosting the growth of the global peptide and anticoagulant drug market.
Full report of Peptide and Anticoagulant Drug Market available @ https://www.omrglobal.com/industry-reports/peptide-and-anticoagulant-market
Market Coverage
Segment Covered-
- By Product
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- are Abbott Laboratories, Johnson & Johnson Services Inc, Bayer AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd. and others .
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Peptide and Anticoagulant Drug Market Report Segment
By Product
- Hormonal
- Antibiotics
- Antifungal
- ACE inhibitors
By Application
- Cardiology
- Gynecology
- Diabetes
- Cancer
- Osteoporosis
- Infectious Diseases
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/peptide-and-anticoagulant-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.